| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Sr. VP, R& D & CSO | Sr. VP & CSO
1 company
Yat Sun Or is Chief Scientific Officer at ENTA. From January 2015 to February 2026, the filings on record show 0 open-market purchases and 13 sales. Yat Sun Or's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.9M at current prices.
Our model assigns Yat Sun Or a middling insider score of 59/100, based on 4 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -1.2%.
The ENTA filings lean toward selling, a net 123,141 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | ENTA Enanta Pharmaceuticals Inc | Chief Scientific Officer | Sell | 3,750 | $42.47 | $159,264.75 | -1.7% | |
| Jun 5, 2015 | ENTA Enanta Pharmaceuticals Inc | Chief Scientific Officer | Sell | 10,750 | $42.02 | $451,662.32 | -4.7% | |
| May 11, 2015 | ENTA Enanta Pharmaceuticals Inc | Chief Scientific Officer | Sell | 8,000 | $36.13 | $289,044.80 | -3.4% |